Cargando…
Gene therapy for spinal muscular atrophy: Solomon's consensus in Covid times
Autor principal: | Zafeiriou, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Paediatric Neurology Society. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441024/ https://www.ncbi.nlm.nih.gov/pubmed/32873505 http://dx.doi.org/10.1016/j.ejpn.2020.08.005 |
Ejemplares similares
-
Gene therapy for spinal muscular atrophy: the benefit–cost profile
Publicado: (2021) -
Rapid molecular diagnosis of spinal muscular atrophy
por: Mittal, Balraj
Publicado: (2012) -
Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018) -
Choosing Life with Spinal Muscular Atrophy Type 1
por: Lavie, Moran, et al.
Publicado: (2020) -
European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
por: Kirschner, Janbernd, et al.
Publicado: (2020)